Trypanosoma brucei gambiense group 2 experimental in vivo life cycle: from procyclic to bloodstream form
Parasite · 2024
DOI: 10.1051/parasite/2024009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Parasite, 2024. Verfasst von Paola Juban und 4 weiteren Autor:innen. Beteiligte Einrichtung: INTERTRYP, Université de Montpellier, Cirad, IRD, Montpellier, France. Hauptthemen laut MEDLINE: Trypanosomiasis, African, Tsetse Flies, Trypanosoma, Trypanosoma brucei brucei. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: KIM RIVE project Montpellier, Département Soutien et Formation, Institut de Recherche pour le Développement.
Abstract (Originalsprache)
Trypanosoma brucei gambiense ( Tbg ) group 2 is a subgroup of trypanosomes able to infect humans and is found in West and Central Africa. Unlike other agents causing sleeping sickness, such as Tbg group 1 and Trypanosoma brucei rhodesiense , Tbg 2 lacks the typical molecular markers associated with resistance to human serum. Only 36 strains of Tbg 2 have been documented, and therefore, very limited research has been conducted despite their zoonotic nature. Some of these strains are only available in their procyclic form, which hinders human serum resistance assays and mechanistic studies. Furthermore, the understanding of Tbg 2’s potential to infect tsetse flies and mammalian hosts is limited. In this study, 165 Glossina palpalis gambiensis flies were experimentally infected with procyclic Tbg 2 parasites. It was found that 35 days post-infection, 43 flies out of the 80 still alive were found to be Tbg 2 PCR-positive in the saliva. These flies were able to infect 3 out of the 4 mice used for blood-feeding. Dissection revealed that only six flies in fact carried mature infections in their midguts and salivary glands. Importantly, a single fly with a mature infection was sufficient to infect a mammalian host. This Tbg 2 transmission success confirms that Tbg 2 strains can establish in tsetse flies and infect mammalian hosts. This study describes an effective in vivo protocol for transforming Tbg 2 from procyclic to bloodstream form, reproducing the complete Tbg 2 cycle from G. p. gambiensis to mice. These findings provide valuable insights into Tbg 2’s host infectivity, and will facilitate further research on mechanisms of human serum resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- INTERTRYP, Université de Montpellier, Cirad, IRD, Montpellier, France.
ORCID-Profile: Sophie Ravel
Förderung
- KIM RIVE project Montpellier
- Département Soutien et Formation, Institut de Recherche pour le Développement
Zitieren
APA
Juban, P., Bart, J. M., Ségard, A., Jamonneau, V., & Ravel, S. (2024). Trypanosoma brucei gambiense group 2 experimental in vivo life cycle: from procyclic to bloodstream form. Parasite. https://doi.org/10.1051/parasite/2024009
Vancouver
Juban P, Bart JM, Ségard A, Jamonneau V, Ravel S. Trypanosoma brucei gambiense group 2 experimental in vivo life cycle: from procyclic to bloodstream form. Parasite. 2024. doi:10.1051/parasite/2024009
BibTeX
@article{Juban2024,
author = {Juban, Paola and Bart, Jean-Mathieu and Ségard, Adeline and Jamonneau, Vincent and Ravel, Sophie},
title = {Trypanosoma brucei gambiense group 2 experimental in vivo life cycle: from procyclic to bloodstream form},
journal = {Parasite},
year = {2024},
doi = {10.1051/parasite/2024009}
}
EUVIMED